+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Global Pediatrics Partnering 2010-2020: Deal Trends, Players and Financials

  • ID: 2237248
  • Report
  • September 2020
  • Region: Global
  • 450 pages
  • CurrentPartnering

Enquire about COVID-19 updates for this product.

Enquire Now


  • 480 Biomedical
  • Brammer Bio
  • Emmes
  • Kuhnil Pharmaceuticals
  • PeriGen
  • Sutro Biopharma
  • MORE
Global Pediatrics Partnering 2010 to 2020 provides the full collection of Pediatrics disease deals signed between the world’s pharmaceutical and biotechnology companies since 2010.
  • Trends in Pediatrics partnering deals
  • Financial deal terms for headline, upfront and royalty by stage of development
  • Pediatrics partnering agreement structure
  • Pediatrics partnering contract documents
  • Top Pediatrics deals by value
  • Most active Pediatrics dealmakers
Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor’s product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element.

The report takes readers through the comprehensive Pediatrics disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Pediatrics deals.

The report presents financial deal terms values for Pediatrics deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.

The initial chapters of this report provide an orientation of Pediatrics dealmaking trends.

Chapter 1 provides an introduction to the report.

Chapter 2 provides an overview of the trends in Pediatrics dealmaking since 2010 covering trends by year, deal type, stage of development, technology type and therapeutic indication.

Chapter 3 includes an analysis of financial deal terms covering headline value, upfront payment, milestone payments and royalty rates.

Chapter 4 provides a review of the leading Pediatrics deals since 2010. Deals are listed by headline value. The chapter includes the top 25 most active Pediatrics dealmakers, together with a full listing of deals to which they are a party. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.

Chapter 5 provides comprehensive access to Pediatrics deals since 2010 where a deal contract is available, providing the user with direct access to contracts as filed with the SEC regulatory authorities. Each deal title links via Weblink to an online version of the deal record contract document, providing easy access to each contract document on demand.

Chapter 6 provides a comprehensive directory of all Pediatrics partnering deals by specific Pediatrics target announced since 2010. The chapter is organized by specific Pediatrics therapeutic target. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

In addition, a comprehensive appendix is provided with each report of all Pediatrics partnering deals signed and announced since 2010. The appendices are organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc) and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The report also includes numerous tables and figures that illustrate the trends and activities in Pediatrics partnering and dealmaking since 2010.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of Pediatrics technologies and products.

Report scope

Global Pediatrics Partnering 2010 to 2020 is intended to provide the reader with an in-depth understanding and access to Pediatrics trends and structure of deals entered into by leading companies worldwide.

Global Pediatrics Partnering 2010 to 2020 includes:
  • Trends in Pediatrics dealmaking in the biopharma industry since 2010
  • Analysis of Pediatrics deal structure
  • Access to headline, upfront, milestone and royalty data
  • Access to hundreds of Pediatrics deal contract documents
  • Comprehensive access to over 500 Pediatrics deal records
  • The leading Pediatrics deals by value since 2010
  • Most active Pediatrics dealmakers since 2010
In Global Pediatrics Partnering 2010 to 2020, available deals and contracts are listed by:
  • Headline value
  • Upfront payment value
  • Royalty rate value
  • Stage of development at signing
  • Deal component type
  • Technology type
  • Specific therapy indication
Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The Global Pediatrics Partnering 2010 to 2020 report provides comprehensive access to available deals and contract documents for over 500 pediatrics deals. Analyzing actual contract agreements allows assessment of the following:
  • What are the precise rights granted or optioned?
  • What is actually granted by the agreement to the partner company?
  • What exclusivity is granted?
  • What is the payment structure for the deal?
  • How are the sales and payments audited?
  • What is the deal term?
  • How are the key terms of the agreement defined?
  • How are IPRs handled and owned?
  • Who is responsible for commercialization?
  • Who is responsible for development, supply, and manufacture?
  • How is confidentiality and publication managed?
  • How are disputes to be resolved?
  • Under what conditions can the deal be terminated?
  • What happens when there is a change of ownership?
  • What sublicensing and subcontracting provisions have been agreed?
  • Which boilerplate clauses does the company insist upon?
  • Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
  • Which jurisdiction does the company insist upon for agreement law?
Note: Product cover images may vary from those shown


  • 480 Biomedical
  • Brammer Bio
  • Emmes
  • Kuhnil Pharmaceuticals
  • PeriGen
  • Sutro Biopharma
  • MORE
Executive Summary

Chapter 1 – Introduction

Chapter 2 – Trends in Pediatrics dealmaking
2.1. Introduction
2.2. Pediatrics partnering over the years
2.3. Pediatrics partnering by deal type
2.4. Pediatrics partnering by industry sector
2.5. Pediatrics partnering by stage of development
2.6. Pediatrics partnering by technology type
2.7. Pediatrics partnering by therapeutic indication

Chapter 3 –Financial deal terms for Pediatrics partnering
3.1. Introduction
3.2. Disclosed financials terms for Pediatrics partnering
3.3. Pediatrics partnering headline values
3.4. Pediatrics deal upfront payments
3.5. Pediatrics deal milestone payments
3.6. Pediatrics royalty rates

Chapter 4 – Leading Pediatrics deals and dealmakers
4.1. Introduction
4.2. Most active in Pediatrics partnering
4.3. List of most active dealmakers in Pediatrics
4.4. Top Pediatrics deals by value

Chapter 5 – Pediatrics contract document directory
5.1. Introduction
5.2. Pediatrics partnering deals where contract document available

Chapter 6 – Pediatrics dealmaking by therapeutic target
6.1. Introduction
6.2. Deals by Pediatrics therapeutic target

Appendix 1 – Directory of Pediatrics deals by company A-Z 2010 to 2020
Appendix 2 – Directory of Pediatrics deals by deal type 2010 to 2020
Appendix 3 – Directory of Pediatrics deals by stage of development 2010 to 2020
Appendix 4 – Directory of Pediatrics deals by technology type 2010 to 2020
Further reading on dealmaking
Deal type definitions

Table of Figures
Figure 1: Pediatrics partnering since 2010
Figure 2: Pediatrics partnering by deal type since 2010
Figure 3: Pediatrics partnering by industry sector since 2010
Figure 4: Pediatrics partnering by stage of development since 2010
Figure 5: Pediatrics partnering by technology type since 2010
Figure 6: Pediatrics partnering by indication since 2010
Figure 7: Pediatrics deals with a headline value
Figure 8: Pediatrics deals with upfront payment values
Figure 9: Pediatrics deals with milestone payment
Figure 10: Pediatrics deals with royalty rates
Figure 11: Active Pediatrics dealmaking activity– 2010 to 2020
Figure 12: Top Pediatrics deals by value since 2010
Note: Product cover images may vary from those shown
  • 480 Biomedical
  • AAVLife
  • AB-Biotics
  • Abbvie
  • Abcam
  • Abeona Therapeutics
  • Abiogen Pharma
  • Achaogen
  • Acorda Therapeutics
  • Adare Pharmaceuticals
  • ADMA Biologics
  • Advaxis
  • Advicenne
  • Aerogen
  • Aevi Genomic Medicine
  • Akili Interactive Labs
  • Akonni Biosystems
  • Albert Einstein College of Medicine
  • Alexion Pharmaceuticals
  • Allegis Holdings
  • American Cancer Society
  • AmerisourceBergen
  • Amicus Therapeutics
  • Antares Pharma
  • Anthera Pharmaceuticals
  • APR Applied Pharma Research
  • Aptevo Therapeutics
  • Ariad Pharmaceuticals
  • Astellas Pharma
  • AstraZeneca
  • Aucta Pharmaceuticals
  • Aurora BioPharma
  • Avadel Pharmaceuticals
  • Avita Medical
  • Awair
  • Axovant Sciences
  • Aytu BioScience
  • Back-A-Line
  • Baebies
  • Battelle
  • Baylor College
  • Baylor College of Medicine
  • Beckman Research Institute of City of Hope
  • Becton Dickinson
  • Beijing Double-Crane Pharmaceutical
  • Bellicum Pharmaceuticals
  • Best Choice
  • Beyond Batten Disease Foundation
  • Bill and Melinda Gates Foundation
  • Biocodex
  • BioGaia
  • Bioiatriki
  • BioInvent
  • BioMarin Pharmaceutical
  • Biomedical Advanced Research and Development Authority
  • BioNano Genomics
  • Biostage
  • Biotechnology Industry Organization
  • Blackrock NeuroMed
  • Boston University
  • Brain Balance Achievement Centers
  • Brammer Bio
  • Brigham and Women's Hospital
  • Bristol-Myers Squibb Foundation
  • Brown University
  • Caladrius Biosciences
  • California Institute for Regenerative Medicine
  • Cambridge Brain Sciences
  • Capnia
  • CareDox
  • Case Western Reserve University
  • Case Western Reserve University School of Medicine
  • CAS Medical Systems
  • Castle Creek Pharmaceuticals
  • CDC Foundation
  • Cell Therapy Catapult
  • Cempra Pharmaceutical
  • Center for Infectious Disease Research
  • Center for Technology and Innovation in Pediatrics (CTIP)
  • Centers for Disease Control and Prevention
  • Centogene
  • Cerecor
  • Certara
  • Chiesi Farmaceutici
  • Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry
  • Children's Cancer Therapy Development Institute
  • Children's Hospital Boston
  • Children's Hospital Los Angeles
  • Children's Hospital of Orange County
  • Children's Hospital of Philadelphia
  • Children's Hospital of Pittsburgh
  • Children's Hospital Of Wisconsin
  • Children's Minnesota
  • Children's National Health System
  • Children's National Medical Center
  • Children’s Hospital Colorado
  • ChromaDex
  • Cincinnati Children’s Hospital Medical Center
  • Claritas Genomics
  • Clear Guide Medical
  • Clevexel Pharma
  • Clinigen
  • Co-Formulate
  • CoapTech
  • Codexis
  • Cognoa
  • CombiMatrix
  • Connecticut Children’s Medical Center
  • Courtagen Life Sciences
  • Covalent Data
  • CromSource
  • Crosscare
  • Cure Duchenne
  • Cures Within Reach
  • Curing Kids Cancer
  • Cypher Genomics
  • Cystinosis Research Foundation
  • Dana-Farber Cancer Institute
  • DARA BioSciences
  • DBV Technologies
  • DeGregorio Family Foundation
  • Delivering Scientific Innovation for Autism (DELSIA)
  • Dell
  • Derbycare
  • Dermelix Biotherapeutics
  • Discovery Laboratories
  • Diurnal
  • Dr. Reddy's Laboratories
  • Drukier Institute for Children's Health
  • DSG
  • Duke University Medical Center
  • Dynacure
  • Edico Genome
  • EffRx
  • Eiger BioPharmaceuticals
  • Eisai Inc
  • Ekso Bonics
  • Elanix Biotechnologies
  • Emergent BioSolutions
  • Emmaus Medical
  • Emmes
  • Emory University
  • EOS Imaging
  • Esophageal Cancer Awareness Association
  • EspeRare Foundation
  • Eunice Kennedy Shriver Institute of Child Health and Human Development
  • Evolve BioSystems
  • Evotec
  • Exeltis
  • Ferring Pharmaceuticals
  • Fibrocell Science
  • Fidia Farmaceutici
  • Flynn Pharma
  • Foundation for the Children of the Californias
  • Foundation for the National Institutes of Health (FNIH)
  • Fred Hutchinson Cancer Research Center
  • FSC Laboratories
  • FSC Pediatrics
  • Fujifilm medical systems
  • Fulgent Genetics
  • Galaxy Health Network
  • GE Healthcare
  • Gemphire
  • Genco Sciences
  • GenePeeks
  • Genzyme
  • GlaxoSmithKline
  • Great Ormond Street Hospital (GOSH)
  • Guilin Pharmaceutical
  • GW Pharmaceuticals
  • Hackensack Meridian Health
  • Hao Le Ku (Beijing) Infant And Maternity
  • Harvard Apparatus Regenerative Technology
  • Harvard University
  • Healthcare Technology Innovation Centre (Chennai)
  • Horizon Pharma plc
  • Hospital for Special Surgery
  • HudsonAlpha Institute for Biotechnology
  • Huntsman Cancer Institute
  • Hyundai Hope On Wheels
  • IDbyDNA
  • Ikaria
  • Illumina
  • Innara Health
  • Innovative Cellular Therapeutics
  • INO Therapeutics
  • Inova Genomics Laboratory
  • Inova Translational Medicine Institute
  • Inserm
  • Institute for Genome Statistics and Bioinformatics
  • Institute of Human Genetics
  • International Isotopes
  • Invenra
  • inVentiv Health
  • Invictus Medical
  • Invitae
  • Ionis Pharmaceuticals
  • Ipsen
  • Janssen Research & Development
  • Jeffrey Modell Foundation
  • Jennewein Biotechnologie
  • Johns Hopkins Kimmel Cancer Center
  • Johns Hopkins University
  • Juvenile Diabetes Research Foundation
  • Kadmon Pharmaceuticals
  • Kaiser Permanente
  • KemPharm
  • KinderPharm
  • Kings College London
  • Knopp Biosciences
  • Kuhnil Pharmaceuticals
  • Lee's Pharmaceutical
  • Live Like Bella Childhood Cancer Foundation
  • Loulou Foundation
  • Lupin Pharmaceuticals
  • Lyomark Pharma
  • Macrogenics
  • Masimo
  • Medgenics
  • Medica Labs
  • Medicines Patent Pool Foundation
  • Medicollector
  • Medidata Solutions
  • Medosome Biotec
  • Memorial Sloan Kettering Cancer Center
  • Merck and Co
  • Mezzion Pharma
  • MilliporeSigma
  • Ministry of Health (Saudi Arabia)
  • Mission Pharmacal
  • Moleculin Biotech
  • MonoSolRx
  • Murdoch Childrens Research Institute
  • Mustang Bio
  • Mylan Pharmaceuticals
  • NantHealth
  • National Cancer Institute
  • National Health and Family Planning Commission
  • National Heart
  • Lung and Blood Institute
  • National Institute of Allergy and Infectious Diseases
  • National Institute of Child Health and Human Development
  • National Institute of Neurological Disorders and Stroke
  • National Institutes of Health
  • National Science Foundation
  • Necker Hospital
  • Nestle Health Science
  • Neurim Pharmaceuticals
  • Neuroblastoma and Medulloblastoma Translational Research
  • NeuroSigma
  • Neurotrope BioScience
  • New England Research Institutes
  • New York Genome Center (NYGC)
  • NextCODE Health
  • Nightstar Therapeutics
  • Noninvasix
  • Nordic Pharma Group
  • Northwestern University
  • Notable Labs
  • Novartis
  • Novartis Institute for Tropical Diseases
  • Noventure
  • Nutra Pharma
  • Nutriband
  • Nutritional Growth Solutions
  • Onconova Therapeutics
  • Oncurious
  • Onxeo
  • OPKO Health
  • Optasia Medical
  • Orchard Therapeutics
  • OrthoPediatrics
  • Ospedale San Raffaele
  • Osteosarcoma Collaborative
  • Ovid Therapeutics
  • Paidion Research
  • Parabase Genomics
  • Pediatric Oncology Experimental Therapeutics Investigators Consortium
  • Penta ID Innovation
  • PeriGen
  • PerkinElmer
  • Pfizer
  • Pharma Base
  • PharmaSwiss
  • Phoenix Children’s Hospital
  • PierianDx
  • Pierre Fabre
  • PlasmaTech Biopharmaceuticals
  • PnuVax
  • PPD
  • Pragma Pharmaceuticals
  • Pressure BioSciences
  • PreventionGenetics
  • Primex Pharmaceuticals
  • Princess Maxima Center for Pediatric Oncology
  • Progenics Pharmaceuticals
  • Progeria Research Foundation
  • Pronto Diagnostics
  • Prophylix Pharma
  • Proveca
  • Provectus Biopharmaceuticals
  • Provention Bio
  • Q-State Biosciences
  • Q BioMed
  • Quotient
  • Rady Children's Institute for Genomic Medicine
  • Rare Genomics Institute
  • Reckitt Benckiser
  • Regeneron Genetics Center
  • Regeneron Pharmaceuticals
  • Regenxbio
  • ReGenX Biosciences
  • Research Institute at Nationwide Children’s Hospital
  • Retrophin
  • Riley Hospital for Children at IU Health
  • Royal Free Hospital
  • Royal Philips Electronics
  • RPRD Diagnostics
  • Saban Research Institute of Children's Hospital Los Angeles
  • Sagent Pharmaceuticals
  • Samsung Bioepis
  • Sanford Burnham Institute
  • Sanford Health
  • Sanofi
  • Saol Therapeutics
  • Seattle Children's Hospital
  • Sequenom
  • Sequenta
  • SFC Fluidics
  • Shionogi Pharma
  • Shriners Hospital for Children
  • Sigma-Tau
  • Sintetica
  • Sohn Conference Foundation
  • Soleno Therapeutics
  • SomaLogic
  • Spineguard
  • SRI International
  • St. Baldrick's Foundation
  • St. Jude Children's Research Hospital
  • Stanford University
  • Stanford University School of Medicine
  • Starlight Children's Foundation
  • StemCyte
  • Supernus Pharmaceuticals
  • Sutro Biopharma
  • Swedish Orphan Biovitrum
  • Synpromics
  • Takeda Pharmaceutical
  • Tanner Pharmaceuticals
  • TB Alliance
  • Tec-Pharm
  • Tessa Therapeutics
  • Texas Children’s Hospital
  • The Children's Oncology Group Foundation
  • The Nemours/Alfred I duPont Hospital for Children
  • Theresia G & Stuart F Kline Family Foundation
  • Thermo Fisher Scientific
  • ThromboGenics
  • Translational Genomics Research Institute
  • Translational Software
  • Trinity Medical Devices
  • Tull Family Foundation
  • Turing Pharmaceuticals
  • UCB
  • UNeMed
  • United Nations Children Fund
  • United Therapeutics
  • University College London
  • University Hospitals Rainbow Babies & Children's Hospital
  • University of Alabama at Birmingham
  • University of Arizona
  • University of Bonn
  • University of Buffalo
  • University of California Los Angeles
  • University of California San Francisco
  • University of California Santa Cruz
  • University of Chicago
  • University of Colorado
  • University of Florida
  • University of Florida Research Foundation
  • University of Kentucky
  • University of Manitoba
  • University of Maryland
  • University of Massachusetts Medical School
  • University of Michigan
  • University of Nebraska
  • University of New South Wales
  • University of North Carolina
  • University of Oxford
  • University of Pennsylvania
  • University of Pittsburgh Cancer Institute
  • University of Texas
  • University of Texas Southwestern Medical Center
  • University of Toledo
  • University of Virginia
  • University of Washington
  • US Bioservices
  • Vericel
  • Vernalis
  • VietPhap International
  • ViiV Healthcare
  • Virginia Commonwealth University
  • VirtualScopics
  • ViS Research Institute
  • VivaLNK
  • Vizient
  • Wanbang Biopharmaceuticals
  • Washington University in St Louis
  • Weill Cornell Medical College
  • Windtree Therapeutics
  • Wisconsin Alumni Research Foundation
  • WishBone Medical
  • Worldwide Clinical Trials
  • Wyeth Nutrition
  • Wyss Institute
  • Yale University
  • Yili Industrial Group
  • Zenyaku Kogyo
Note: Product cover images may vary from those shown
  • The publisher reports provide insight into the trends and terms of partnering deals in the global life sciences sector.
  • The publisher reports are updated every six months to ensure the user has access to the latest announcements and trends in the topic focus of the report.
  • The publisher analysts review the deal data to provide an overview and analysis of deal trends, including example deals and terms.
  • The publisher reports source deal data from our proprietary deals and alliances database. The database is updated daily by our analysts with new deals as they are announced globally by the company’s party to the deal.
  • The data in the deals and alliances database is obtained from secondary sources such as publicly available industry sources including press releases, company presentations, investor presentations, company SEC filings, other company filings, company websites, conference presentations. Sources are identified to allow for user verification.

The publisher provides comprehensive coverage of the following partnering or deal types:

  • Asset purchase
  • Assignment
  • Co-development
  • Co-market
  • Co-promotion
  • Collaborative R&D
  • Contract service
  • Cross-licensing
  • Development
  • Distribution
  • Equity purchase
  • Evaluation
  • Grant
  • Joint venture
  • Licensing
  • Loan
  • Manufacturing
  • Marketing
  • Option
  • Promotion
  • Research
  • Royalty financing
  • Settlement
  • Spin out
  • Sub license
  • Supply
  • Termination
  • Warrant

Every deal record is fully categorized and includes the following data, where available:

  • Industry sector
  • Therapy areas
  • Technology type
  • Deal components
  • Financial terms
  • Stage of development
  • Exclusivity
  • Asset type
  • Geographic focus
  • Excluded geography
  • Company press release
  • SEC filing data including contract document

All financial amounts are converted to US$ using the exchange rate available on the date of deal announcement, enabling direct comparison of deal terms across international territories.